Article: Molecular advances in severe acute respiratory syndrome-associated coronavirus (SARS-CoV).

File Download Links for fulltext
(May Require Subscription)
Supplementary
  • Basic View
  • Metadata View
  • XML View
TitleMolecular advances in severe acute respiratory syndrome-associated coronavirus (SARS-CoV).
AuthorsChow, KY1
Hon, CC1
Hui, RK1
Wong, RT1
Yip, CW1
Zeng, F1
Leung, FC1
Issue Date2003
PublisherKexue Chubanshe.
CitationGenomics Proteomics Bioinformatics, 2003, v. 1 n. 4, p. 247-262 [How to Cite?]
AbstractThe sudden outbreak of severe acute respiratory syndrome (SARS) in 2002 prompted the establishment of a global scientific network subsuming most of the traditional rivalries in the competitive field of virology. Within months of the SARS outbreak, collaborative work revealed the identity of the disastrous pathogen as SARS-associated coronavirus (SARS-CoV). However, although the rapid identification of the agent represented an important breakthrough, our understanding of the deadly virus remains limited. Detailed biological knowledge is crucial for the development of effective countermeasures, diagnostic tests, vaccines and antiviral drugs against the SARS-CoV. This article reviews the present state of molecular knowledge about SARS-CoV, from the aspects of comparative genomics, molecular biology of viral genes, evolution, and epidemiology, and describes the diagnostic tests and the anti-viral drugs derived so far based on the available molecular information.
ISSN1672-0229
2011 SCImago Journal Rankings: 0.097
DC Field
Value
dc.contributor.authorChow, KY
dc.contributor.authorHon, CC
dc.contributor.authorHui, RK
dc.contributor.authorWong, RT
dc.contributor.authorYip, CW
dc.contributor.authorZeng, F
dc.contributor.authorLeung, FC
dc.date.accessioned2010-09-06T08:58:16Z
dc.date.available2010-09-06T08:58:16Z
dc.date.issued2003
dc.description.abstractThe sudden outbreak of severe acute respiratory syndrome (SARS) in 2002 prompted the establishment of a global scientific network subsuming most of the traditional rivalries in the competitive field of virology. Within months of the SARS outbreak, collaborative work revealed the identity of the disastrous pathogen as SARS-associated coronavirus (SARS-CoV). However, although the rapid identification of the agent represented an important breakthrough, our understanding of the deadly virus remains limited. Detailed biological knowledge is crucial for the development of effective countermeasures, diagnostic tests, vaccines and antiviral drugs against the SARS-CoV. This article reviews the present state of molecular knowledge about SARS-CoV, from the aspects of comparative genomics, molecular biology of viral genes, evolution, and epidemiology, and describes the diagnostic tests and the anti-viral drugs derived so far based on the available molecular information.
dc.description.natureLink_to_subscribed_fulltext
dc.identifier.citationGenomics Proteomics Bioinformatics, 2003, v. 1 n. 4, p. 247-262 [How to Cite?]
dc.identifier.epage262
dc.identifier.hkuros85755
dc.identifier.issn1672-0229
2011 SCImago Journal Rankings: 0.097
dc.identifier.issue4
dc.identifier.openurl
dc.identifier.pmid15629054
dc.identifier.scopuseid_2-s2.0-13844281686
dc.identifier.spage247
dc.identifier.urihttp://hdl.handle.net/10722/84886
dc.identifier.volume1
dc.languageeng
dc.publisherKexue Chubanshe.
dc.publisher.placeChina
dc.relation.ispartofGenomics Proteomics Bioinformatics
dc.titleMolecular advances in severe acute respiratory syndrome-associated coronavirus (SARS-CoV).
dc.typeArticle
Author Affiliations
  1. The University of Hong Kong